TickerFactsScreenerDevelopers

Protara Therapeutics, Inc. (TARA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$72.66M2012: -$86.66M2013: -$100.51M2014: $82.46M2015: $63.41M2016: $38.44M2017: $34.74M2018: $4.78M2019: -$2.13M2020: $199.24M2021: $161.91M2022: $102.08M2023: $68.32M2024: $167.13M2025: $196.41M$196.41M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$196.41M+17.5%
2024$167.13M+144.6%
2023$68.32M-33.1%
2022$102.08M-37.0%
2021$161.91M-18.7%
2020$199.24M+9462.9%
2019-$2.13M-144.5%
2018$4.78M-86.2%
2017$34.74M-9.6%
2016$38.44M-39.4%
2015$63.41M-23.1%
2014$82.46M+182.0%
2013-$100.51M-16.0%
2012-$86.66M-19.3%
2011-$72.66M—